News related to Viread (Tenofovir Disoproxil) and/or conditions it is approved for
Anti-HIV Pill Could Cut Infections in Gay, Bi Men by a Third
Source: Medscape HIV/AIDS Headlines [2016.07.18]
The rate of new HIV infections among gay and bisexual men could drop by up to a third over the next decade if enough eligible men use pre-exposure prophylaxis (PrEP) with Truvada (emtricitabine/tenofovir disoproxil fumarate), researchers estimate.
Reuters Health Information
FDA OKs HIV 'Quad' Pill
Source: MedPage Today Product Alert [2012.08.28]
WASHINGTON -- The FDA has approved Stribild, the four-drug combination of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, for once-daily treatment of HIV in adults who have never received HIV treatment.